Idiopathic Pulmonary Fibrosis
Annals of ATS
- Health Care Utilization and Costs of Idiopathic Pulmonary Fibrosis in U.S. Medicare Beneficiaries Aged 65 Years and Older
- Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
- My journey through Idiopathic Pulmonary Fibrosis
ATS Statements
- An Official ATS/ACCP Statement: The Choosing Wisely Top 5 List in Adult Pulmonary Medicine (2014)
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias (2013)
- An Official ATS Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis In Interstitial Lung Disease (2012)
- An Official ATS Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis In Interstitial Lung Disease(2012) - Online Supplement
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management (2011) Being revised.
- NIH/NHLBI Notice re: 3-drug Regimen for IPF (2011)
- An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses (2008)
- Statement on Home Care for Patients with Respiratory Disorders (2005)
Patient Fact Sheets
Other ATS Resources
